| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
24,753 |
22,462 |
$2.74M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
6,289 |
4,841 |
$2.05M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
12,579 |
11,327 |
$1.66M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,769 |
4,024 |
$638K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,301 |
1,912 |
$569K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,889 |
1,600 |
$498K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,738 |
1,414 |
$456K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,770 |
2,529 |
$342K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
824 |
719 |
$195K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,327 |
1,056 |
$175K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
976 |
828 |
$143K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,165 |
1,049 |
$139K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
545 |
463 |
$138K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
3,613 |
3,311 |
$127K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
429 |
255 |
$80K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
373 |
320 |
$69K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
477 |
454 |
$63K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
392 |
389 |
$63K |
| G0378 |
Hospital observation service, per hour |
840 |
412 |
$62K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
5,623 |
5,014 |
$61K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
558 |
456 |
$46K |
| 76830 |
Ultrasound, transvaginal |
453 |
393 |
$35K |
| 72131 |
|
484 |
414 |
$30K |
| 93971 |
|
407 |
366 |
$30K |
| 93356 |
|
94 |
89 |
$26K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
17,109 |
14,571 |
$26K |
| 71250 |
|
358 |
310 |
$26K |
| 71046 |
Radiologic examination, chest; 2 views |
1,903 |
1,746 |
$22K |
| 62323 |
|
59 |
56 |
$21K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
163 |
124 |
$19K |
| 76642 |
|
157 |
149 |
$18K |
| 82805 |
|
559 |
421 |
$18K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
621 |
540 |
$15K |
| G0260 |
Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography |
96 |
58 |
$15K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,381 |
1,083 |
$13K |
| 12001 |
|
71 |
68 |
$11K |
| 71045 |
Radiologic examination, chest; single view |
5,145 |
4,526 |
$10K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
7,665 |
6,484 |
$9K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
180 |
158 |
$8K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
115 |
101 |
$8K |
| 73030 |
|
565 |
500 |
$7K |
| 93970 |
|
52 |
49 |
$7K |
| 84484 |
|
6,704 |
4,018 |
$6K |
| 74018 |
|
189 |
161 |
$6K |
| 73562 |
|
382 |
319 |
$5K |
| 96367 |
|
136 |
96 |
$5K |
| 73630 |
|
717 |
637 |
$5K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
19,785 |
16,996 |
$5K |
| 72110 |
|
93 |
79 |
$5K |
| 90715 |
|
293 |
238 |
$5K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
307 |
247 |
$5K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
5,941 |
5,254 |
$4K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
8,508 |
7,092 |
$4K |
| 73130 |
|
478 |
432 |
$4K |
| 93017 |
|
45 |
40 |
$4K |
| 73610 |
|
597 |
526 |
$4K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
20 |
12 |
$4K |
| 80076 |
|
5,656 |
4,714 |
$3K |
| 73502 |
|
196 |
179 |
$3K |
| J3490 |
Unclassified drugs |
1,290 |
919 |
$3K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
14 |
14 |
$3K |
| 76536 |
|
24 |
24 |
$3K |
| 80053 |
Comprehensive metabolic panel |
2,028 |
1,690 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,624 |
2,721 |
$3K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,862 |
2,509 |
$2K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
5,780 |
4,450 |
$2K |
| 70486 |
|
94 |
81 |
$2K |
| 70496 |
|
13 |
12 |
$2K |
| 73110 |
|
329 |
297 |
$2K |
| 81001 |
|
7,951 |
6,732 |
$2K |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
94 |
52 |
$2K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
28 |
27 |
$2K |
| 73080 |
|
122 |
111 |
$2K |
| 72128 |
|
48 |
37 |
$1K |
| 73560 |
|
186 |
145 |
$1K |
| 97162 |
|
17 |
12 |
$1K |
| 96376 |
|
1,144 |
726 |
$1K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
180 |
158 |
$1K |
| 83690 |
|
5,578 |
4,615 |
$1K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
77 |
70 |
$973.69 |
| 83735 |
|
1,248 |
939 |
$965.72 |
| 72100 |
|
65 |
58 |
$919.01 |
| 77065 |
Tomosynthesis, mammo |
30 |
26 |
$890.70 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
508 |
404 |
$882.84 |
| 87529 |
|
787 |
391 |
$863.69 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
508 |
404 |
$764.50 |
| 81025 |
|
4,032 |
3,374 |
$752.11 |
| 29125 |
|
294 |
261 |
$640.81 |
| 86900 |
|
26 |
24 |
$639.37 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
484 |
387 |
$605.88 |
| 87634 |
|
321 |
278 |
$563.87 |
| 81003 |
|
1,985 |
1,705 |
$544.12 |
| 71101 |
|
33 |
29 |
$535.03 |
| 77066 |
Tomosynthesis, mammo |
12 |
12 |
$457.48 |
| 85027 |
|
650 |
471 |
$437.28 |
| 84443 |
Thyroid stimulating hormone (TSH) |
812 |
701 |
$429.58 |
| 85378 |
|
1,264 |
1,093 |
$407.22 |
| 83605 |
|
1,145 |
787 |
$398.93 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
797 |
680 |
$390.74 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
86 |
44 |
$384.31 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,400 |
1,003 |
$369.03 |
| 73590 |
|
30 |
26 |
$360.89 |
| 87040 |
|
941 |
405 |
$355.86 |
| 84702 |
|
241 |
196 |
$350.28 |
| 83880 |
|
543 |
465 |
$311.33 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
741 |
518 |
$278.75 |
| 80320 |
|
101 |
82 |
$257.09 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
86 |
65 |
$249.73 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
5,858 |
4,705 |
$203.09 |
| 87210 |
|
219 |
182 |
$185.41 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
343 |
338 |
$180.38 |
| 87077 |
|
440 |
362 |
$170.07 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
429 |
196 |
$161.19 |
| 86141 |
|
72 |
68 |
$154.24 |
| J2800 |
Injection, methocarbamol, up to 10 ml |
27 |
24 |
$147.41 |
| 84145 |
|
418 |
340 |
$138.61 |
| 85610 |
|
753 |
584 |
$132.67 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
267 |
217 |
$127.53 |
| 73090 |
|
20 |
13 |
$107.80 |
| 73140 |
|
30 |
24 |
$102.90 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
106 |
66 |
$101.05 |
| 85651 |
|
263 |
213 |
$90.82 |
| 87186 |
|
365 |
306 |
$90.74 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,814 |
1,266 |
$88.44 |
| 85007 |
|
337 |
257 |
$83.21 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
663 |
449 |
$81.71 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
400 |
299 |
$77.53 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
4,998 |
3,869 |
$68.77 |
| 82550 |
|
241 |
188 |
$62.77 |
| 86901 |
|
26 |
24 |
$49.19 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,350 |
1,031 |
$46.33 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
918 |
705 |
$32.52 |
| J2060 |
Injection, lorazepam, 2 mg |
171 |
124 |
$29.52 |
| 87070 |
|
71 |
71 |
$25.65 |
| J1790 |
Injection, droperidol, up to 5 mg |
243 |
187 |
$24.85 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
700 |
445 |
$24.21 |
| 85730 |
|
231 |
181 |
$24.03 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
80 |
77 |
$21.64 |
| 36415 |
Collection of venous blood by venipuncture |
18 |
13 |
$19.68 |
| J1644 |
Injection, heparin sodium, per 1000 units |
148 |
73 |
$15.98 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
47 |
37 |
$11.40 |
| 81015 |
|
108 |
98 |
$9.36 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
715 |
649 |
$9.20 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
535 |
413 |
$7.21 |
| J2704 |
Injection, propofol, 10 mg |
323 |
148 |
$4.95 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
339 |
272 |
$2.33 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
19 |
14 |
$1.47 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
18 |
12 |
$1.17 |
| J1940 |
Injection, furosemide, up to 20 mg |
19 |
14 |
$1.05 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
603 |
318 |
$0.31 |
| J3480 |
Injection, potassium chloride, per 2 meq |
17 |
12 |
$0.00 |
| J3360 |
Injection, diazepam, up to 5 mg |
26 |
13 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
162 |
132 |
$0.00 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
32 |
27 |
$0.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
28 |
26 |
$0.00 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
19 |
14 |
$0.00 |
| 84703 |
|
17 |
14 |
$0.00 |
| 70498 |
|
13 |
12 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
14 |
12 |
$0.00 |
| 82010 |
|
157 |
124 |
$0.00 |
| J0689 |
Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg |
71 |
67 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
131 |
103 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
32 |
25 |
$0.00 |